Viewing Study NCT04551066

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:39 PM
Ignite Modification Date: 2026-02-01 @ 6:03 AM
Study NCT ID: NCT04551066
Status: TERMINATED
Last Update Posted: 2025-10-21
First Post: 2020-09-11
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313)
Sponsor: Incyte Corporation
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myelofibrosis View
None Primary Myelofibrosis View
None Post Essential Thrombocythemia Myelofibrosis View
None Post Polycythemia Vera Myelofibrosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None INCB050465 View
None ruxolitinib View
None parsaclisib View
None LIMBER View
None MF View
None Myelofibrosis View
None Myeloproliferative Neoplasms View
None Myoproliferative Neoplasms View